Innoviva - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsInnoviva

Innoviva(INVA)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

cluster headache

,

breast neoplasms

,

,

,

type 2 diabetes mellitus

,

diabetes mellitus

,

,

diabetic nephropathies

,

Cephalosporin c

bacterial infections

multiple myeloma

,

plasma cell neoplasms

,

,

myeloid leukemia acute

,

deficiency diseases

,

paraproteinemias

,

,

precursor cell lymphoblastic leukemia-lymphoma

,

breast neoplasms

,

immune system diseases

,

hematologic neoplasms

,

type 2 diabetes mellitus

,

,

metabolic diseases

,

,

glycogen storage disease

,

,

immunoglobulin g4-related disease

,

,

myeloid leukemia

,

,

falciparum malaria

,

,

,

,

,

polycystic kidney diseases

,

autosomal dominant polycystic kidney

,

,

,

renal insufficiency

,

hematologic diseases

,

blood protein disorders

,

neoplasms by histologic type

,

prostatic neoplasms

,

circulating neoplastic cells

,

x-linked bulbo-spinal atrophy

,

heart transplantation

,

non-small-cell lung carcinoma

,

nasopharyngeal carcinoma

,

nasopharyngeal neoplasms

,

esophageal neoplasms

,

,

neoplasm metastasis

,

aplastic anemia

,

multiple myeloma

,

hypercholesterolemia

,

meningococcal infections

,

plasma cell neoplasms

,

hemolytic anemia autoimmune

,

,

meningococcal meningitis

,

stomach neoplasms

,

,

kidney diseases

,

gaucher disease

,

,

chronic renal insufficiency

,

hyperphosphatemia

,

multiple sclerosis

,

,

homozygous familial hypercholesterolemia

,

hyperlipoproteinemia type ii

,

,

,

healthy volunteers/patients

,

,

glycogen storage disease type ii

,

atopic dermatitis

,

diabetes mellitus

,

insulin resistance

,

,

glycogen storage disease type iii

,

,

non-hodgkin lymphoma

,

,

postmenopausal osteoporosis

,

,

lymphoproliferative disorders

,

hodgkin disease

,

myeloid leukemia acute

,

breast neoplasms

,

mucinous adenocarcinoma

,

ductal carcinoma breast

,

inflammatory breast neoplasms

,

,

chemotherapy-induced febrile neutropenia

,

non-hodgkin lymphoma

,

,

mantle-cell lymphoma

,

promyelocytic leukemia acute

,

,

non-hodgkin lymphoma

,

,

b-cell chronic lymphocytic leukemia

,

macular degeneration

,

,

communicable diseases

,

bacterial infections

,

methicillin-resistant staphylococcus aureus

,

staphylococcal skin infections

,

infectious skin diseases

,

bacterial skin diseases

,

acinetobacter infections

Fluoroquinolone

rheumatoid arthritis

,

healthy volunteers/patients

,

,

head and neck neoplasms

,

squamous cell carcinoma

,

squamous cell neoplasms

,

,

,

,

pulmonary tuberculosis

,

prostatic neoplasms

,

urinary tract infections

,

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use